We are live on ! Find out more
AURA icon

Aura Biosciences
AURA

59 hedge funds and large institutions have $334M invested in Aura Biosciences in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 12

44% more capital invested

Capital invested by funds: $233M → $334M (+$102M)

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

5.28% more ownership

Funds ownership: 66.32% → 71.6% (+5.3%)

4% more funds holding

Funds holding: 57 → 59 (+2)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more call options, than puts

Call options by funds: $12K | Put options by funds: $12K

Holders
59
Holders Change
+2
Holders Change %
+3.51%
% of All Funds
0.93%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
32
Reduced
12
Closed
5
Calls
$12K
Puts
$12K
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$7.89M
2
BlackRock
BlackRock
New York
+$5.78M
3
EAM
Eventide Asset Management
Massachusetts
+$4.38M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$4.38M
5
State Street
State Street
Massachusetts
+$1.12M

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$3.93M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$482K
3
Citadel Advisors
Citadel Advisors
Florida
-$445K
4
NCM
Nantahala Capital Management
Connecticut
-$429K
5
Millennium Management
Millennium Management
New York
-$290K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCMC
1
Matrix Capital Management Company
New Hampshire
$66.2M – – –
MVM
2
Medicxi Ventures Management
Jersey
$37.5M – – –
EAM
3
Eventide Asset Management
Massachusetts
$36.3M +$4.38M +409,689 +16%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$33.5M – – –
Citadel Advisors
5
Citadel Advisors
Florida
$30.4M -$445K -41,640 -2%
BlackRock
6
BlackRock
New York
$23.1M +$5.78M +541,032 +41%
Vanguard Group
7
Vanguard Group
Pennsylvania
$12.7M -$218K -20,415 -2%
Goldman Sachs
8
Goldman Sachs
New York
$12.7M +$7.89M +738,406 +256%
RSCM
9
Rock Springs Capital Management
Maryland
$12.6M – – –
NCM
10
Nantahala Capital Management
Connecticut
$9.92M -$429K -40,121 -5%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$8.22M -$482K -45,077 -6%
RCM
12
Regency Capital Management
Hawaii
$6.57M -$121K -11,342 -2%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$6.17M +$446K +41,688 +9%
State Street
14
State Street
Massachusetts
$5.6M +$1.12M +104,712 +30%
Bank of Montreal
15
Bank of Montreal
Ontario, Canada
$5.21M +$4.38M +409,574 New
Fidelity Investments
16
Fidelity Investments
Massachusetts
$4.43M +$19.1K +1,789 +0.5%
DCMIC
17
Decheng Capital Management III (Cayman)
Cayman Islands
$3.62M – – –
Northern Trust
18
Northern Trust
Illinois
$2.63M +$190K +17,817 +9%
LFCM
19
Long Focus Capital Management
Puerto Rico
$2.23M +$94K +8,798 +5%
Citigroup
20
Citigroup
New York
$1.83M -$3.93M -367,546 -71%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$1.02M +$193K +18,064 +28%
Morgan Stanley
22
Morgan Stanley
New York
$996K +$86.3K +8,072 +11%
Charles Schwab
23
Charles Schwab
California
$898K +$99.5K +9,310 +15%
LCS
24
Levin Capital Strategies
New York
$865K +$588K +55,000 +367%
Verition Fund Management
25
Verition Fund Management
Connecticut
$769K +$433K +40,474 +186%
1
2 3

AURA Hedge Fund Activity: Q2 2023 in Review

59 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q2 2023, worth a combined $334M — up 44% from $233M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AURA positions and 5 closed out — a net gain of 2 holders — while 32 added to existing stakes and 12 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $7.89M. The largest seller was Citigroup, cutting an estimated $3.93M.

  • 59 institutional investors held Aura Biosciences (AURA) as of Q2 2023, up from 57 in Q1 2023.
  • Funds reported $334M of Aura Biosciences stock for Q2 2023, up 44% quarter-over-quarter.
  • 7 funds opened new Aura Biosciences positions in Q2 2023 and 5 closed out, a net change of +2 holders.
  • The largest Aura Biosciences buyer in Q2 2023 was Goldman Sachs, an estimated $7.89M added.
  • The largest Aura Biosciences seller in Q2 2023 was Citigroup, an estimated $3.93M sold.

Based on aggregated 13F filings for Q2 2023.